-
2
-
-
0030952289
-
-
W. Risau Nature 386 1997 671
-
(1997)
Nature
, vol.386
, pp. 671
-
-
Risau, W.1
-
3
-
-
15344340324
-
-
TM (Bevacizumab) has recently been approved to treat colorectal cancer see: C. Culy Drugs Today 41 2005 23
-
(2005)
Drugs Today
, vol.41
, pp. 23
-
-
Culy, C.1
-
5
-
-
0033947625
-
-
G. Bold, K-H. Altmann, F. Jorg, M. Lang, P.W. Manley, P. Traxler, B. Wietfeld, J. Bruggen, E. Buchdunger, R. Cozens, S. Ferrari, F. Pascal, F. Hofmann, G. Martiny-Baron, J. Mestan, J. Rosel, M. Sills, D. Stover, F. Acemoglu, E. Boss, R. Emmenegger, L. Lasser, E. Masso, R. Roth, C. Schlachter, W. Vetterli, D. Wyss, and J.M. Wood J. Med. Chem. 43 2000 2310
-
(2000)
J. Med. Chem.
, vol.43
, pp. 2310
-
-
Bold, G.1
Altmann, K.-H.2
Jorg, F.3
Lang, M.4
Manley, P.W.5
Traxler, P.6
Wietfeld, B.7
Bruggen, J.8
Buchdunger, E.9
Cozens, R.10
Ferrari, S.11
Pascal, F.12
Hofmann, F.13
Martiny-Baron, G.14
Mestan, J.15
Rosel, J.16
Sills, M.17
Stover, D.18
Acemoglu, F.19
Boss, E.20
Emmenegger, R.21
Lasser, L.22
Masso, E.23
Roth, R.24
Schlachter, C.25
Vetterli, W.26
Wyss, D.27
Wood, J.M.28
more..
-
6
-
-
0037075812
-
-
L.F. Hennequin, E.S.E. Stokes, A.P. Thomas, C. Johnstone, P.A. Ple, D.J. Ogilvie, M. Dukes, S.R. Wedge, J. Kendrew, and J.O. Curwen J. Med. Chem. 45 2002 1300
-
(2002)
J. Med. Chem.
, vol.45
, pp. 1300
-
-
Hennequin, L.F.1
Stokes, E.S.E.2
Thomas, A.P.3
Johnstone, C.4
Ple, P.A.5
Ogilvie, D.J.6
Dukes, M.7
Wedge, S.R.8
Kendrew, J.9
Curwen, J.O.10
-
7
-
-
20144370978
-
-
S.R. Wedge, J. Kendrew, L.F. Hennequin, P.J. Valentine, S.T. Barry, S.R. Brave, N.R. Smith, N.H. James, M. Dukes, J.O. Curwen, R. Chester, J.A. Jackson, S.J. Boffey, L.L. Kilburn, S. Barnett, G.H.P. Richmond, P.F. Wadsworth, M. Walker, A.L. Bigley, S.T. Taylor, L. Cooper, S. Beck, J.M. Juergensmeier, and D.J. Ogilvie Cancer Res. 65 2005 4389
-
(2005)
Cancer Res.
, vol.65
, pp. 4389
-
-
Wedge, S.R.1
Kendrew, J.2
Hennequin, L.F.3
Valentine, P.J.4
Barry, S.T.5
Brave, S.R.6
Smith, N.R.7
James, N.H.8
Dukes, M.9
Curwen, J.O.10
Chester, R.11
Jackson, J.A.12
Boffey, S.J.13
Kilburn, L.L.14
Barnett, S.15
Richmond, G.H.P.16
Wadsworth, P.F.17
Walker, M.18
Bigley, A.L.19
Taylor, S.T.20
Cooper, L.21
Beck, S.22
Juergensmeier, J.M.23
Ogilvie, D.J.24
more..
-
8
-
-
29544450179
-
-
P.W. Manley, P. Furet, G. Bold, J. Brüggen, J. Mestan, T. Meyer, C. Schnell, and J. Wood J. Med. Chem. 45 2002 5697
-
(2002)
J. Med. Chem.
, vol.45
, pp. 5697
-
-
Manley, P.W.1
Furet, P.2
Bold, G.3
Brüggen, J.4
Mestan, J.5
Meyer, T.6
Schnell, C.7
Wood, J.8
-
9
-
-
3042747695
-
-
P.W. Manley, G. Bold, G. Fendrich, P. Furet, J. Mestan, T. Meyer, B. Meyhack, A. Strauss, and J. Wood Cell. Mol. Biol. Lett. 8 2003 532
-
(2003)
Cell. Mol. Biol. Lett.
, vol.8
, pp. 532
-
-
Manley, P.W.1
Bold, G.2
Fendrich, G.3
Furet, P.4
Mestan, J.5
Meyer, T.6
Meyhack, B.7
Strauss, A.8
Wood, J.9
-
10
-
-
29544443706
-
-
U.S. Patent 6,878,720 B2, 2005.
-
Altmann, K.-H.; Bold, G.; Furet, P.; Manley, P. W.; Wood, J. M.; Ferrari, S.; Hofmann, F.; Mestan, J.; Huth, A.; Krüger, M.; Seidelmann, D.; Menrad, A.; Haberey, M.; Thierauch, K.-H. U.S. Patent 6,878,720 B2, 2005.
-
-
-
Altmann, K.-H.1
Bold, G.2
Furet, P.3
Manley, P.W.4
Wood, J.M.5
Ferrari, S.6
Hofmann, F.7
Mestan, J.8
Huth, A.9
Krüger, M.10
Seidelmann, D.11
Menrad, A.12
Haberey, M.13
Thierauch, K.-H.14
-
11
-
-
25144461671
-
-
E.L. Piatnitski, M. Duncton, R. Katoch-Rouse, D. Sherman, A.S. Kiselyov, D. Milligan, C. Balagtas, W. Wong, J. Kawakami, and J. Doody Bioorg. Med. Chem. 15 2005 4696
-
(2005)
Bioorg. Med. Chem.
, vol.15
, pp. 4696
-
-
Piatnitski, E.L.1
Duncton, M.2
Katoch-Rouse, R.3
Sherman, D.4
Kiselyov, A.S.5
Milligan, D.6
Balagtas, C.7
Wong, W.8
Kawakami, J.9
Doody, J.10
-
12
-
-
29544443045
-
-
note
-
3OS: C, 59.38; H, 4.10; N, 12.22. Found: C, 59.23; H, 4.21, N, 12.04.
-
-
-
-
13
-
-
29544446433
-
-
note
-
2, 2 mM DTT, and 1 mg/ml BSA) containing 0.5 mmol pGAT-biotin and 3-4 ng KDR enzyme was added to each well. After 5-10 min preincubation, the kinase reaction was initiated by the addition of 10 μl of 10 μM ATP in the reaction buffer, after which the plate was incubated at room temperature for 45 min. The reaction was stopped by addition of 50 μl KF buffer (50 mM Hepes, pH 7.5, 0.5 M KF, and 1 mg/ml BSA) containing 100 mM EDTA and 0.36 μg/ml PY20K (Eu-cryptate labeled anti-phosphotyrosine antibody, CIS Bio International) was added and after an additional 2 h incubation at RT, the plate was analyzed in a RUBYstar HTRF Reader.
-
-
-
-
14
-
-
0033103867
-
-
M.A. McTigue, J.A. Wickersham, C. Pinko, R.E. Showalter, C.V. Parast, A. Tempczyk-Russell, M.R. Gehring, B. Mroczkowski, C.C. Kan, J.E. Villafranca, and K. Appelt Structure 7 1999 319
-
(1999)
Structure
, vol.7
, pp. 319
-
-
McTigue, M.A.1
Wickersham, J.A.2
Pinko, C.3
Showalter, R.E.4
Parast, C.V.5
Tempczyk-Russell, A.6
Gehring, M.R.7
Mroczkowski, B.8
Kan, C.C.9
Villafranca, J.E.10
Appelt, K.11
-
15
-
-
0033954256
-
-
H.M. Berman, J. Westbrook, Z. Feng, G. Gilliland, T.N. Bhat, H. Weissig, I.N. Shindyalov, and P.E. Bourne Nucleic Acids Res. 28 2000 235
-
(2000)
Nucleic Acids Res.
, vol.28
, pp. 235
-
-
Berman, H.M.1
Westbrook, J.2
Feng, Z.3
Gilliland, G.4
Bhat, T.N.5
Weissig, H.6
Shindyalov, I.N.7
Bourne, P.E.8
-
20
-
-
29544452180
-
-
note
-
4 and absorbance was measured at 450 nm.
-
-
-
|